Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Choose France: investment projects announced for Dunkirk

22 Jan 2020 | Front page, Health Nutrition, Investment

Coca-Cola and AstraZeneca announce major investments in the Hauts-de-France region at the third Choose France summit.

 

Choose France: major groups invest in Hauts-de-France companies

After the announcement a few days ago of a second production line at the Toyota site in Valenciennes, two more major companies in the Hauts-de-France region yesterday announced substantial investments in France and the region:

 

  • Coca-Cola, the soft drink giant that has had a presence in Dunkirk for 30 years, will invest €1 billion in France over five years
  • AstraZeneca, the biopharmaceutical group which has had a site in Dunkirk for a quarter of a century, plans an investment of €500M in France by 2025

 

With these investments, a significant portion of which will be targeted at the regions, the two foreign companies reaffirm their confidence in Hauts-de-France and their satisfaction with doing business there.

Coca-Cola invests €1 billion over five years

Coca-Cola, a major player in the food industry, has announced a €1 billion investment in France. The money, shared equally by the Coca-Cola group and its French subsidiary Coca-Cola European Partners, will be distributed across the brand’s five production sites.

The Hauts-de-France plant is expected to benefit from a large share of the investment in Coca-Cola’s bottling plant. CCEP announced the creation of a “new state-of-the-art aseptic bottling line”. Based in Socx, near Dunkirk, this site is one of the group’s three largest in Europe.

To read more about the history of CCEP in Hauts-de-France, see our July article.

For its part, the Coca-Cola Company wants to support the launch of new drink ranges in France (notably Fuze Tea and Tropico), while accelerating the development of its existing brands.

This is a strategic joint investment ahead of the Paris 2024 Olympic Games for which the Coca-Cola group is a sponsor.

Find out more about the agrifood sector in Hauts-de-France

AstraZeneca invests €230 million in Dunkirk

Following a €135 million extension to its Dunkirk site, the Anglo-Swedish pharmacy giant plans to reinject €230 million over five years. This sum is part of an overall investment of €500 million in France. It should allow the Hauts-de-France factory, the group's global centre of excellence, to increase in productivity thanks to:

 

  • The creation of new production lines (an autonomous assembly line and assembly and packaging lines)
  • The modernisation of existing infrastructure
  • The recruitment of a hundred highly-qualified new employees

 

Also note: the group is currently working on the opening of a freight shipping line between the port of Calais and the United States.

Find out more about the health sector in Hauts-de-France

 

 

Back to news

News

Durisotti, confidence regained

One year on, what benefit has Durisotti derived from its takeover by the British GFG Alliance? And what effect has Covid had on the newly acquired company?

Obesity: Lille’s University Hospital (CHU) becomes a European pilot site

With state of the art technology, Lille’s CHU is experimenting with a new procedure in the fight against obesity: the B-Clamp. The first of its kind in Europe.

All news